Literature DB >> 23061745

Exploring genomic structure differences and similarities between the Greek and European HapMap populations: implications for association studies.

Vasileios Stathias1, Georgios R Sotiris, Iordanis Karagiannidis, Georgios Bourikas, Georgios Martinis, Dimitrios Papazoglou, Anna Tavridou, Nikolaos Papanas, Efstratios Maltezos, Marios Theodoridis, Vassilios Vargemezis, Vangelis G Manolopoulos, William C Speed, Judith R Kidd, Kenneth K Kidd, Petros Drineas, Peristera Paschou.   

Abstract

Studies of the genomic structure of the Greek population and Southeastern Europe are limited, despite the central position of the area as a gateway for human migrations into Europe. HapMap has provided a unique tool for the analysis of human genetic variation. Europe is represented by the CEU (Northwestern Europe) and the TSI populations (Tuscan Italians from Southern Europe), which serve as reference for the design of genetic association studies. Furthermore, genetic association findings are often transferred to unstudied populations. Although initial studies support the fact that the CEU can, in general, be used as reference for the selection of tagging SNPs in European populations, this has not been extensively studied across Europe. We set out to explore the genomic structure of the Greek population (56 individuals) and compare it to the HapMap TSI and CEU populations. We studied 1112 SNPs (27 regions, 13 chromosomes). Although the HapMap European populations are, in general, a good reference for the Greek population, regions of population differentiation do exist and results should not be light-heartedly generalized. We conclude that, perhaps due to the individual evolutionary history of each genomic region, geographic proximity is not always a perfect guide for selecting a reference population for an unstudied population.
© 2012 The Authors Annals of Human Genetics © 2012 Blackwell Publishing Ltd/University College London.

Entities:  

Mesh:

Year:  2012        PMID: 23061745     DOI: 10.1111/j.1469-1809.2012.00730.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  4 in total

1.  Pharmacogenomic assessment of Mexican and Peruvian populations.

Authors:  Sharon Marsh; Cristi R King; Derek J Van Booven; Jane Y Revollo; Robert H Gilman; Howard L McLeod
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

2.  Assessment of Parkinson's disease risk loci in Greece.

Authors:  Eleanna Kara; Georgia Xiromerisiou; Cleanthe Spanaki; Maria Bozi; Georgios Koutsis; Marios Panas; Efthimios Dardiotis; Styliani Ralli; Jose Bras; Christopher Letson; Connor Edsall; Hannah Pliner; Sampath Arepalli; Kallirhoe Kalinderi; Liana Fidani; Sevasti Bostantjopoulou; Margaux F Keller; Nicholas W Wood; John Hardy; Henry Houlden; Leonidas Stefanis; Andreas Plaitakis; Dena Hernandez; Georgios M Hadjigeorgiou; Mike A Nalls; Andrew B Singleton
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

3.  Association of rs11780592 Polymorphism in the Human Soluble Epoxide Hydrolase Gene (EPHX2) with Oxidized LDL and Mortality in Patients with Diabetic Chronic Kidney Disease.

Authors:  Stefanos Roumeliotis; Athanasios Roumeliotis; Aikaterini Stamou; Stylianos Panagoutsos; Vangelis G Manolopoulos; Fotis Tsetsos; Marianthi Georgitsi; Vassilios Liakopoulos
Journal:  Oxid Med Cell Longev       Date:  2021-05-06       Impact factor: 6.543

4.  Comparative analysis of rs12979860 SNP of the IFNL3 gene in children with hepatitis C and ethnic matched controls using 1000 Genomes Project data.

Authors:  Giuseppe Indolfi; Giusi Mangone; Elisa Bartolini; Gabriella Nebbia; Pier Luigi Calvo; Maria Moriondo; Pier-Angelo Tovo; Maurizio de Martino; Chiara Azzari; Massimo Resti
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.